Clinical Unpublished Data: Allogeneic Gamma Delta Immunotherapy for Acute Myeloid Leukemia
Time: 3:30 pm
day: Conference Day One
Details:
- Novel findings on VD2s and VD1s remain unpublished currently
- Research aims to evaluate the efficacy, safety, and potential benefits of gamma delta cell therapy in treating AcutAML
- Signifying the emergence of gamma delta cell therapy as a promising novel approach in AML management
